Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ESPR - Esperion Therapeutics, Inc.
50.5 M
LAST VALUE
-56.63%
2 YEAR CAGR
36.38%
5 YEAR CAGR
-5.53%
10 YEAR CAGR